The Surface Acoustic Wave (SAW) Biosensors segmentation by application distinguishes five primary end‑use domains that collectively drive market revenue. Medical diagnostics, accounting for roughly 38 % of total sales, leverages SAW platforms for point‑of‑care pathogen detection and biomarker quantification, where high sensitivity and rapid response translate into premium pricing. Environmental monitoring contributes about 27 % as regulators adopt SAW devices for real‑time detection of pollutants, gases, and water‑borne contaminants; the recurring testing contracts underpin a stable volume base. Food‑safety testing represents 18 % of the market, with manufacturers integrating SAW sensors into production lines to verify microbial load and allergen presence, generating moderate‑margin sales. Industrial process control accounts for 12 % by embedding SAW sensors in equipment to monitor temperature, pressure, and chemical composition, where bulk procurement reduces unit price but sustains demand. Finally, security and defense applications, though niche at 5 %, employ SAW biosensors for biochemical threat identification, adding a specialized, high‑value segment. Together these application sub‑segments define the overall market size and growth trajectory.